Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 243.52 | 212.83 | 224.62 | 344.03 | 364.39 |
| Operating profit | 72.14 | 68.14 | 97.35 | 169.88 | 174.63 |
| Interest | 2.29 | 1.27 | 0.50 | 1.15 | 2.29 |
| Gross profit | 86.72 | 80.84 | 111.05 | 178.79 | 183.09 |
| EPS (Rs) | 2.10 | 2.06 | 2.94 | 4.88 | 5.11 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 16.87 | 13.97 | 14.20 | 10.06 | 10.75 |
| Stock adjustment | 17.02 | 6.39 | 8.97 | 21.50 | 20.88 |
| Raw material | 63.16 | 60.65 | 46.95 | 77.62 | 89.57 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 37.10 | 30.62 | 26.51 | 26.27 | 22.90 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | 2.01 |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 54.10 | 47.03 | 44.83 | 48.75 | 54.41 |
| Provisions made | - | - | - | - | - |
| Depreciation | 15.66 | 11.33 | 10.48 | 11.15 | 10.63 |
| Taxation | 17.62 | 17.14 | 25.84 | 43.35 | 42.30 |
| Net profit / loss | 53.43 | 52.36 | 74.73 | 124.29 | 130.16 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 25.46 | 25.46 | 25.46 | 25.46 | 25.46 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 29.62 | 32.01 | 43.34 | 49.38 | 47.92 |
| GPM (%) | 33.30 | 35.64 | 46.50 | 50.49 | 48.81 |
| NPM (%) | 20.52 | 23.09 | 31.29 | 35.10 | 34.70 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis